Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320

Avi Kenny¹, Janine van Duijn², One Dintwe³, Jack Heptinstall⁴, Randy Burnham⁵, Sheetal Sawant⁴, Lu Zhang⁴, Dieter Mielke⁶, Sharon Khuzwayo⁷, Faatima Laher Omar⁷, Sherry Stanfield-Oakley⁶, Taylor Keyes⁶, Brooke Dunn⁶, Derrick Goodman⁴, Youyi Fong⁸, David Benkeser⁹, Rodger Zou⁵, John Hural⁵, Ollivier Hyrien⁵, Michal Juraska⁵, Alex Luedtke¹⁰, Lars van der Laan¹¹, Elena E Giorgi⁵, Craig Magaret⁵, Lindsay N Carpp⁵, Laura Pattacini², Tom van de Kerkhof², Bette Korber¹², Wouter Willems¹³, Leigh H Fisher⁵, Hanneke Schuitemaker², Edith Swann¹⁴, James G Kublin⁵, Maria G Pau¹⁵, Susan Buchbinder¹⁶, Frank Tomaka¹⁷, Steven Nijs¹⁵, Ludo Lavreys¹⁵, Huub C Gelderblom⁵, Lawrence Corey¹⁸, Kathryn Mngadi¹⁹, Glenda E Gray²⁰, Erica Borducchi²¹, Jenny Hendriks², Kelly E Seaton⁴, Susan Zolla-Pazner²², Dan H Barouch²³, Guido Ferrari⁴, Stephen C De Rosa⁵, M Juliana McElrath²⁴, Erica Andersen-Nissen³, Daniel J Stieh², Georgia D Tomaras²⁵, Peter B Gilbert²⁶; Imbokodo Study and Correlates Group

Collaborators, Affiliations

Collaborators

Imbokodo Study and Correlates Group:
Jon Allagappen, Jessica Andriesen, Alison Ayres, Saman Baral, Linda-Gail Bekker, Asiphe Besethi, Caroline Borremans, Esmee Braams, Caroline Brackett, William Brumskine, Roma Chilengi, Rachel Choi, Thozama Dubula, Jaiden Seongmi Dumas, Brooke Dunn, Radhika Etikala, Zelda Euler, Sarah Everett, Nigel Garrett, Huub Gelderblom, Katherine Gill, Kevin Gillespie, Dimitri Goedhart, Erik Goosmann, Shannon Grant, Ellie Hands, Barton Haynes, Bronwill Herringer, Zaheer Hoosain, Mina Hosseinipour, Portia Hunidzarira, Julia Hutter, Mubiana Inambao, Craig Innes, Taylor Keyes, William Kilembe, Philippus Kotze, Sheena Kotze, Fatima Laher, Imre Laszlo, Erica Lazarus, Hua-Xin Liao, Yong Lin, Helen Lu, Judith Lucas, Mookho Malahleha, Tara McNair, Peter Meerts, Zinhle Mgaga, Mahlodi Montlha, Boitumelo Mosito, Andrew Moultrie, Sarah Mudrak, Valérie Oriol-Mathieu, Marcella Sarzotti-Kelsoe, Matson Tso Mathebula, Mitch Matoga, Rachael McClennen, Pamela Mda, Peter Meerts, Vimla Naicker, Logashvari Naidoo, Cindy-Ann Okkers, Saleha Omarjee, Hella Pasmans, Tricia Philip, Abraham Pinter, Annah Pitsi, Ornelia Ramos, April Randhawa, Sanne Roels, Shamiska Rohith, Lucy Rutten, Jerald Sadoff, Gabriela Salinas, Yvonne Salzgeber, Lorenz Scheppler, Katharine Schwedhelm, Nicolette Schuller, Angelina Sharak, Sherry Stanfield-Oakley, Carrie Sopher, Terence Tafatatha, Simbarashe G Takuva, Chan Tang, An Vandebosch, Edna Viegas, Valentin Voillet, Frank Wegmann, Mo Weijtens, Stephany Wilcox, Anthony Williams, Chenchen Yu, Pei-Chun Yu, Olive Yuan, Xuehan Zhang

Affiliations

¹ Department of Biostatistics, University of Washington, Seattle, WA, USA.
² Janssen Vaccines & Prevention BV, Leiden, the Netherlands.
³ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
⁴ Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.
⁵ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
⁶ Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA.
⁷ Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
⁸ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
⁹ Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
¹⁰ Department of Statistics, University of Washington, Seattle, WA, USA.
¹¹ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Statistics, University of Washington, Seattle, WA, USA.
¹² Los Alamos National Laboratory, Los Alamos, NM, USA; New Mexico Consortium, Los Alamos, NM, USA.
¹³ Janssen Research & Development BE, Beerse, Belgium.
¹⁴ Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
¹⁵ Janssen Infectious Diseases BV, Beerse, Belgium.
¹⁶ San Francisco Department of Public Health, San Francisco, CA, USA.
¹⁷ Janssen Research & Development, LLC, Titusville, NJ, USA.
¹⁸ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, 98195, USA.
¹⁹ The Aurum Institute, Johannesburg, South Africa.
²⁰ South African Medical Research Council, Cape Town, South Africa.
²¹ Center for Virology & Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
²² Icahn School of Medicine at Mount Sinai, New York, NY, USA.
²³ Center for Virology & Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA.
²⁴ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
²⁵ Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA; Department of Integrative Immunobiology, Duke University, Durham, NC, USA. Electronic address: georgia.tomaras@duke.edu.
²⁶ Department of Biostatistics, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address: pgilbert@fredhutch.org.

PMID: 40850015
DOI: 10.1016/j.ebiom.2025.105874

Free article

Published Erratum

Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320

Avi Kenny et al. EBioMedicine. 2025 Sep.

Free article

. 2025 Sep:119:105874.

doi: 10.1016/j.ebiom.2025.105874. Epub 2025 Aug 23.

Authors

Collaborators

Imbokodo Study and Correlates Group:
Jon Allagappen, Jessica Andriesen, Alison Ayres, Saman Baral, Linda-Gail Bekker, Asiphe Besethi, Caroline Borremans, Esmee Braams, Caroline Brackett, William Brumskine, Roma Chilengi, Rachel Choi, Thozama Dubula, Jaiden Seongmi Dumas, Brooke Dunn, Radhika Etikala, Zelda Euler, Sarah Everett, Nigel Garrett, Huub Gelderblom, Katherine Gill, Kevin Gillespie, Dimitri Goedhart, Erik Goosmann, Shannon Grant, Ellie Hands, Barton Haynes, Bronwill Herringer, Zaheer Hoosain, Mina Hosseinipour, Portia Hunidzarira, Julia Hutter, Mubiana Inambao, Craig Innes, Taylor Keyes, William Kilembe, Philippus Kotze, Sheena Kotze, Fatima Laher, Imre Laszlo, Erica Lazarus, Hua-Xin Liao, Yong Lin, Helen Lu, Judith Lucas, Mookho Malahleha, Tara McNair, Peter Meerts, Zinhle Mgaga, Mahlodi Montlha, Boitumelo Mosito, Andrew Moultrie, Sarah Mudrak, Valérie Oriol-Mathieu, Marcella Sarzotti-Kelsoe, Matson Tso Mathebula, Mitch Matoga, Rachael McClennen, Pamela Mda, Peter Meerts, Vimla Naicker, Logashvari Naidoo, Cindy-Ann Okkers, Saleha Omarjee, Hella Pasmans, Tricia Philip, Abraham Pinter, Annah Pitsi, Ornelia Ramos, April Randhawa, Sanne Roels, Shamiska Rohith, Lucy Rutten, Jerald Sadoff, Gabriela Salinas, Yvonne Salzgeber, Lorenz Scheppler, Katharine Schwedhelm, Nicolette Schuller, Angelina Sharak, Sherry Stanfield-Oakley, Carrie Sopher, Terence Tafatatha, Simbarashe G Takuva, Chan Tang, An Vandebosch, Edna Viegas, Valentin Voillet, Frank Wegmann, Mo Weijtens, Stephany Wilcox, Anthony Williams, Chenchen Yu, Pei-Chun Yu, Olive Yuan, Xuehan Zhang

Affiliations

¹ Department of Biostatistics, University of Washington, Seattle, WA, USA.
² Janssen Vaccines & Prevention BV, Leiden, the Netherlands.
³ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
⁴ Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.
⁵ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
⁶ Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA.
⁷ Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
⁸ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
⁹ Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
¹⁰ Department of Statistics, University of Washington, Seattle, WA, USA.
¹¹ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Statistics, University of Washington, Seattle, WA, USA.
¹² Los Alamos National Laboratory, Los Alamos, NM, USA; New Mexico Consortium, Los Alamos, NM, USA.
¹³ Janssen Research & Development BE, Beerse, Belgium.
¹⁴ Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
¹⁵ Janssen Infectious Diseases BV, Beerse, Belgium.
¹⁶ San Francisco Department of Public Health, San Francisco, CA, USA.
¹⁷ Janssen Research & Development, LLC, Titusville, NJ, USA.
¹⁸ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, 98195, USA.
¹⁹ The Aurum Institute, Johannesburg, South Africa.
²⁰ South African Medical Research Council, Cape Town, South Africa.
²¹ Center for Virology & Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
²² Icahn School of Medicine at Mount Sinai, New York, NY, USA.
²³ Center for Virology & Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA.
²⁴ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
²⁵ Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA; Department of Integrative Immunobiology, Duke University, Durham, NC, USA. Electronic address: georgia.tomaras@duke.edu.
²⁶ Department of Biostatistics, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address: pgilbert@fredhutch.org.

PMID: 40850015
DOI: 10.1016/j.ebiom.2025.105874

No abstract available

PubMed Disclaimer

Erratum for

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study.
Kenny A, van Duijn J, Dintwe O, Heptinstall J, Burnham R, Sawant S, Zhang L, Mielke D, Khuzwayo S, Omar FL, Stanfield-Oakley S, Keyes T, Dunn B, Goodman D, Fong Y, Benkeser D, Zou R, Hural J, Hyrien O, Juraska M, Luedtke A, van der Laan L, Giorgi EE, Magaret C, Carpp LN, Pattacini L, van de Kerkhof T, Korber B, Willems W, Fisher LH, Schuitemaker H, Swann E, Kublin JG, Pau MG, Buchbinder S, Tomaka F, Nijs S, Lavreys L, Gelderblom HC, Corey L, Mngadi K, Gray GE, Borducchi E, Hendriks J, Seaton KE, Zolla-Pazner S, Barouch DH, Ferrari G, De Rosa SC, McElrath MJ, Andersen-Nissen E, Stieh DJ, Tomaras GD, Gilbert PB; Imbokodo Study and Correlates Group. Kenny A, et al. EBioMedicine. 2024 Oct;108:105320. doi: 10.1016/j.ebiom.2024.105320. Epub 2024 Sep 4. EBioMedicine. 2024. PMID: 39236556 Free PMC article. Clinical Trial.

Publication types

Actions

Grants and funding

UM1 AI068635/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320

Collaborators

Affiliations

Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320

Authors

Collaborators

Affiliations

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources